Last reviewed · How we verify
NCT03870724
Women and Risk of Type 2 Diabetes
trial in Type 2 Diabetes Mellitus in 383 participants. Completed in 30 March 2022.
30 March 2022
Quick facts
| Lead sponsor | University of Oslo |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 383 |
| Start date | 27 August 2019 |
| Primary completion | 30 March 2022 |
| Estimated completion | 30 March 2022 |
| Sites | 1 location across Norway |
Conditions studied
- Type 2 Diabetes Mellitus — all drugs for Type 2 Diabetes Mellitus →
Sponsor
University of Oslo
Who can join
Adults 27 to 60, female only, with Type 2 Diabetes Mellitus. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This is a follow-up survey of women, 10-12 years after they were included in the population-based Stork Groruddalen study of pregnant women, primarily set up to study gestational diabetes and related health issues in pregnancy in a multiethnic population. The investigators will now update the information about the health status of these women to study the development of risk factors for type 2 diabetes and cardiovascular diseases.
Publications & conference data
3 peer-reviewed publications reference this trial (live from Europe PMC):
-
Cohort profile update: the Norwegian STORK Groruddalen (STORK G) pregnancy and birth cohort-the role of ethnicity and causal pathways for obesity, type 2 diabetes, cardiovascular disease and other health issues.
Waage CW, Toftemo I, Brænd AM, Sletner L, et al · · 2023 · cited 7× · PMID 37899145 · DOI 10.1136/bmjopen-2023-076251 -
Diabetes and prediabetes among women universally screened for gestational diabetes: a multi-ethnic, population-based, prospective study with eleven years follow-up.
Waage CW, Jenum AK, Mdala I, Lee-Ødegård S, et al · · 2025 · cited 1× · PMID 40181282 · DOI 10.1186/s12889-025-22493-x -
Symptom burden in middle-aged women, the role of immigrant status.
Shakeel N, Jenum AK, Waage CW, Mdala I, et al · · 2025 · PMID 41184925 · DOI 10.1186/s12889-025-25093-x
Verify or expand the search:
- PubMed search for NCT03870724
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Type 2 Diabetes Mellitus
Currently open trials in the same condition.
- NCT07351058 — A Clinical Study to Evaluate the Effects of RO7795068 in Participants With Obesity or Overweight and Type 2 Diabetes · Phase 3 · recruiting
- NCT07373938 — Carotid Wall Texture as a Cardiovascular Risk Biomarker in Type 2 Diabetes Mellitus · recruiting
- NCT07433062 — A Study to Evaluate the Effect of AZD6793 on the Pharmacokinetics and Pharmacodynamics of Metformin in Participants With · Phase 1 · recruiting
- NCT07276776 — An Evaluation of the Omnipod® M System in Adults With Type 2 Diabetes · NA · active not recruiting
- NCT07232537 — An Observational Study Called FINE-REAL Korea to Learn More About the Use of the Drug Finerenone in People With Chronic · recruiting
Other University of Oslo trials
Trials by the same sponsor.
- NCT07346911 — Digital Interventions for Relapse Prevention in Adolescence · NA · not yet recruiting
- NCT07499219 — Preliminary Testing and Development of a Short Digital Intervention for Patients on Waiting Lists for Psychological Trea · NA · not yet recruiting
- NCT07408687 — Mechanisms Of Change in Psychotherapy: The Effects of Cognitive Behavioral Therapy and Psychodynamic Therapy in Once - V · NA · not yet recruiting
- NCT07287072 — Pain Reprocessing Therapy for Chronic Primary Pain · NA · not yet recruiting
- NCT07428694 — From Bench to Bedside: A Machine Learning Tool for the Detection of Inspiratory Leak · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03870724 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Oslo
- Last refreshed: 3 November 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03870724.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing